Cortexyme, Inc.
USD1.95
+0.05 (+2.63%)
CEO
Casey Lynch
IPO Date
2019-05-09
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.91
Prev. Close
$1.90
Day Low
$1.86
Day High
$1.97
Market Cap
$0.07B
Volume
0.27M
| $3.23 |
| 9 Jun 2022 | Senner Christopher J. | director: | A-Award | Acquired | 27,000 | $0.00 |
| 9 Jun 2022 | Lamond David | director: | A-Award | Acquired | 27,000 | $0.00 |
| 9 Jun 2022 | Lamond David | director | A-Award | Acquired | 27,000 | $3.23 |
| 9 Jun 2022 | McLoughlin Margaret | director | A-Award | Acquired | 27,000 | $3.23 |
| 9 Jun 2022 | McLoughlin Margaret | director: | A-Award | Acquired | 27,000 | $0.00 |
| 8 Jun 2022 | McDowell Caryn Gordon | Chief Legal & Adm. Officer | F-InKind | Disposed | 6,700 | $2.86 |
| 8 Jun 2022 | McDowell Caryn Gordon | Chief Legal & Adm. Officer | S-Sale | Disposed | 10,800 | $2.86 |
| 8 Jun 2022 | Holsinger Leslie | EVP, Preclinical Development | F-InKind | Disposed | 10,920 | $2.86 |